BC Week In Review | Feb 1, 2016
Company News

Salvat, Lee’s Pharmaceutical Holdings Ltd. deal

Salvat granted Lee’s exclusive rights to develop and commercialize Duoxal ciprofloxacin plus fluocinolone otic solution in Taiwan and China, including Macau and Hong Kong. Lee’s will conduct registration activities in the regions and will have...
BC Week In Review | Jun 3, 2013
Clinical News

Ciprofloxacin plus fluocinolone otic solution: Completed Phase III enrollment

Salvat completed enrollment of 330 pediatric patients with AOM in the first of 2 identical, double-blind Phase III trials to evaluate ciprofloxacin plus fluocinolone otic solution vs. ciprofloxacin or fluocinolone alone for 7 days. Preliminary...
Items per page:
1 - 2 of 2